Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Fox

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Journal of Pharmaceutical Sciences|September 23, 2014
Quantitative measurement of Toll-like receptor 4 agonists adsorbed to Alhydrogel(®) by Fourier transform infrared-attenuated total reflectance spectroscopyQuinton M Dowling, Alicia M Schwartz, Thomas S Vedvick, et al.
Journal of the American Chemical Society|November 16, 2012
Microscopic rates of peptide-phospholipid bilayer interactions from single-molecule residence timesGrant A Myers, Daniel A Gacek, Eric M Peterson, et al.
Vaccine|January 17, 2017
Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolyticaMayuresh M Abhyankar, Zannatun Noor, Mark A Tomai, et al.
Vaccine|December 8, 2010
Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsionsSusan L Baldwin, Christopher B Fox, Mark A Pallansch, et al.
Colloids and Surfaces. B, Biointerfaces|April 29, 2008
Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsionsChristopher B Fox, Ryan C Anderson, Timothy S Dutill, et al.
Biomacromolecules|December 15, 2015
Molecular Design of Squalene/Squalane Countertypes via the Controlled Oligomerization of Isoprene and Evaluation of Vaccine Adjuvant ApplicationsKevin Adlington, Jaouad El Harfi, Jianing Li, et al.
Pharmaceutics|December 23, 2022
Formulated Phospholipids as Non-Canonical TLR4 AgonistsHong Liang, William R Lykins, Emilie Seydoux, et al.
Colloids and Surfaces. B, Biointerfaces|October 15, 2013
In vitro evaluation of TLR4 agonist activity: formulation effectsAyesha Misquith, H W Millie Fung, Quinton M Dowling, et al.
Toxicon : Official Journal of the International Society on Toxinology|July 26, 2023
Physicochemical and immunological effects of adjuvant formulations with snake venom antigens for immunization of horses for antivenom productionChristopher B Fox, Amit P Khandhar, Lisa Khuu, et al.
Plos One|August 29, 2024
An adjuvant formulation containing Toll-like Receptor 7 agonist stimulates protection against morbidity and mortality due to Anaplasma marginale in a highly endemic region of west AfricaJames E Futse, Songliedong Zumor-Baligi, Charles N K Ashiagbor, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Journal of Pharmaceutical Sciences|September 23, 2014
Quantitative measurement of Toll-like receptor 4 agonists adsorbed to Alhydrogel(®) by Fourier transform infrared-attenuated total reflectance spectroscopyQuinton M Dowling, Alicia M Schwartz, Thomas S Vedvick, et al.
Journal of the American Chemical Society|November 16, 2012
Microscopic rates of peptide-phospholipid bilayer interactions from single-molecule residence timesGrant A Myers, Daniel A Gacek, Eric M Peterson, et al.
Vaccine|January 17, 2017
Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolyticaMayuresh M Abhyankar, Zannatun Noor, Mark A Tomai, et al.
Vaccine|December 8, 2010
Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsionsSusan L Baldwin, Christopher B Fox, Mark A Pallansch, et al.
Colloids and Surfaces. B, Biointerfaces|April 29, 2008
Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsionsChristopher B Fox, Ryan C Anderson, Timothy S Dutill, et al.
Biomacromolecules|December 15, 2015
Molecular Design of Squalene/Squalane Countertypes via the Controlled Oligomerization of Isoprene and Evaluation of Vaccine Adjuvant ApplicationsKevin Adlington, Jaouad El Harfi, Jianing Li, et al.
Pharmaceutics|December 23, 2022
Formulated Phospholipids as Non-Canonical TLR4 AgonistsHong Liang, William R Lykins, Emilie Seydoux, et al.
Colloids and Surfaces. B, Biointerfaces|October 15, 2013
In vitro evaluation of TLR4 agonist activity: formulation effectsAyesha Misquith, H W Millie Fung, Quinton M Dowling, et al.
Toxicon : Official Journal of the International Society on Toxinology|July 26, 2023
Physicochemical and immunological effects of adjuvant formulations with snake venom antigens for immunization of horses for antivenom productionChristopher B Fox, Amit P Khandhar, Lisa Khuu, et al.
Plos One|August 29, 2024
An adjuvant formulation containing Toll-like Receptor 7 agonist stimulates protection against morbidity and mortality due to Anaplasma marginale in a highly endemic region of west AfricaJames E Futse, Songliedong Zumor-Baligi, Charles N K Ashiagbor, et al.
Pageof 15